Prescription Drug Affordability & Innovation

Printed Materials

“Getting to the Root of Prescription Drug Prices: Issue Brief.” Waxman, H., Corr, B., Martin, K., and Duong, S. The Commonwealth Fund. July 2017. Available at http://allh.us/pd3r

“Commercially-Insured Patients Pay Undiscounted List Prices for One In Five Brand Prescriptions, Accounting for Half of Out-of-Pocket Spending on Brand Medicines.” PhRMA Foundation. March 29, 2017. Available at http://allh.us/VjUb

“Prescriptions for Competition, Value, and Innovation: Positive Reforms to Increase Access and Affordability for Prescription Drugs.” Council for Affordable Health Coverage. May 2017. Available at http://allh.us/n4r9

“Ten Challenges in the Prescription Drug Market—and Ten Solutions”. The Brookings Institution. May 2, 2017. Available at http://allh.us/cErK

“The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform,” A. S. Kesselheim, J. Avorn, and A. Sarpatwari. JAMA. August 2016. Available at http://allh.us/ntjU

“Value-Based Pricing for Pharmaceuticals in the Trump Administration.” Sachs, R., Bagley, M., and Lakdawalla, D. Health Affairs Blog. April 27, 2017. Available at http://allh.us/4PeE

Additional Materials

“A Data Book: Health Care Spending and the Medicare Program. Section 10: Prescription Drugs” MedPAC. June 2017. Available at http://allh.us/3ct4

“Exclusive: White House Task Force Echoes Pharma Proposals.” Kopp, E. Kaiser Health News. June 16, 2017. Available at http://allh.us/7VmQ

“Gottlieb: FDA to Issue New Policies to Streamline Generic Reviews in 2017.” Mezher, M. Regulatory Affairs Professionals Society. July 18, 2017. Available at http://allh.us/3tBQ

“Health Policy Brief: Biosimilars.” McCaughan, M., Kesselheim, A., Coukell, A., and Tollen, L. Health Affairs. July 21, 2017. Available at http://allh.us/qwvW

“Health Policy Brief: Expedited Approval Pathways.” McCaughan, M., Kesselheim, A., Coukell, A., and Tollen, L. Health Affairs. July 21, 2017. Available at http://allh.us/PmaM

“Health Policy Brief: Pricing Orphan Drugs.” McCaughan, M., Kesselheim, A., Coukell, A., and Tollen, L. Health Affairs. July 21, 2017. Available at http://allh.us/WVJT

“How Congress Can Make Drug Pricing More Rational.” Gottlieb, S. Forbes. September 12, 2016. Available at http://allh.us/kb3Q

“In Drug Price Hearing, Congress Tries to Answer Some Basic Questions.” Tirrell, M. CNBC. June 13, 2017. Available at http://allh.us/3APf.

“PCMA Policy Recommendations.” Merritt, M. Pharmaceutical Care Management Association. July 13, 2017. Available at http://allh.us/ewvR

“Policy Proposal: Banning or Limiting Reverse Payment Agreements.” Coukell, A. and Shih, C. The Pew Charitable Trusts. June 19, 2017. Available at http://allh.us/YE9W

“Policy Proposal: Importation of Prescription Drugs.” Coukell, A. and Shih, C. The Pew Charitable Trusts. April 11, 2017. Available at http://allh.us/97MK.

“Policy Proposal: Improving Generic and Biosimilar Developer Access to Brand Pharmaceutical Samples.” Coukell, A. and Shih, C. The Pew Charitable Trusts. May 30, 2017. Available at http://allh.us/feXB

“Prescription Drug Pricing is Not Just an Election Issue.” Wilensky, G. The Milbank Quarterly. December 2016. Available at http://allh.us/Kk8Q

“The Hutchins Center Explains: Prescription Drug Spending.” Olsen, P. and Sheiner, L. The Brookings Institution. April 26, 2017. Available at http://allh.us/qRNT

“The Trump Administration Says a New Plan Will Cut Drug Prices. It’s Not That Simple.” Mershon, E. STAT. July 14, 2017. Available at http://allh.us/v3PY

“Trump Administration Signals Initial Steps to Deal with Drug Prices.” Johnson, C. The Washington Post. June 21, 2017. Available at http://allh.us/CXf7